Abaloparatide Injection (80 mcg): Clinical Trials

2 trials of Abaloparatide Injection (80 mcg), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Abaloparatide Injection (80 mcg): new trials by email Literature Review of Abaloparatide Injection (80 mcg) trials Research Report on Abaloparatide Injection (80 mcg)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Therapies After Osteoanabolic Treatment
Zoledronate, Denosumab, Teriparatide - Osteoporosis, Postmenopausal
Recruiting424 General Military Hospital1502023-11-252026-07-22
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
Abaloparatide Transdermal (50 mcg), Abaloparatide Transdermal (100 mcg), Abaloparatide Transdermal (150 mcg) - Post Menopausal Osteoporosis
Phase 2CompletedRadius Health, Inc.2502012-09-252020-06-16

Conditions studied

Osteoporosis, Postmenopausal (2)  ·  Osteoporosis (1)

Sponsors

424 General Military Hospital (1)  ·  Radius Health, Inc. (1)

Countries

Denmark (1)  ·  Estonia (1)  ·  Greece (1)  ·  Italy (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Willem Lems, Prof (1)